<DOC>
	<DOC>NCT01789112</DOC>
	<brief_summary>Electric stimulation by cardial contractility modulation (CCM)to improve contractility and physical capacity</brief_summary>
	<brief_title>Acute Neurotrophic Effects of a Non Excitatory Cardial Stimulation by Optimizer III System in Patients With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>planned CCM Implantation systolic left ventricular dysfunction despite of adequate therapy of heart failure (NYHA II, III, IV) implanted pacemaker, defibrillator or pacemaker during CS intubation written informed consent open entryways anemia Hemoglobin (HB)&lt;8 mg/dl lying coronary sinus (CS) tube or CS being not able to intubate chronic atrial fibrillation or flutter mechanic tricuspid valve prothesis no access via subclavian vein patients with VVI pacemaker being stimulated 110% idiopathic hypertrophic cardiomyopathy, restrictive constrictive cardiomyopathy or heart failure because of known inflammatory or infiltrative illnesses or constrictive illness acute myocardial ischemia presented by angina pectoris or ECG changes under load patients being hospitalized because of heart failure during the last month and have to be treated with intravenous diuretics or inotropic substances acute coronary syndrome should not be implanted for at least 3 month patients with mechanic aortic or tricuspid valve patients after heart transplantation patients with clinical significant ectopy, defined by &gt; 8.900 PVCs during 24 hours at beginning Holter monitoring patients after hypertensive crisis patients with acute renal failure Ejection Fraction (EF) &gt; 35 patients after left ventricular pacemaker electrode pregnant or breast feeding women patients with heart failure after sepsis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>